The Cigna Group (CI) FY2025 Q1 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2025-01-01 to 2025-03-31

Swipe to see the full flow
The Cigna Group cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Read chart description and values below for full signed amounts, including zero items.Net (loss) income → Net cash from operating activities: $1,409,000,000.00Insurance liabilities → Operating adjustments reconciliation: $1,778,000,000.00Inventories → Operating adjustments reconciliation: $1,517,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $674,000,000.00Other, net → Operating adjustments reconciliation: $260,000,000.00Pharmacy and other service costs payable → Operating adjustments reconciliation: $135,000,000.00Investment losses, net → Operating adjustments reconciliation: $2,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $511,000,000.00Operating adjustments reconciliation → Accounts receivable, net: $2,205,000,000.00Operating adjustments reconciliation → Accounts payable and Accrued expenses and other liabilities: $1,174,000,000.00Operating adjustments reconciliation → Reinsurance recoverable and Other assets: $219,000,000.00Operating adjustments reconciliation → Deferred income tax benefit: $216,000,000.00Operating adjustments reconciliation → (Gain) loss on sale of businesses: $41,000,000.00Divestitures, net of cash sold → investing reconciliation: $2,346,000,000.00Other sales, maturities and repayments (primarily short-term and other long-term investments) → investing reconciliation: $331,000,000.00Debt securities and equity securities → investing reconciliation: $222,000,000.00Debt securities and equity securities → investing reconciliation: $94,000,000.00Commercial mortgage loans → investing reconciliation: $85,000,000.00investing reconciliation → Net cash from investing activities: $1,197,000,000.00investing reconciliation → Debt securities and equity securities: $952,000,000.00investing reconciliation → Other (primarily short-term and other long-term investments): $475,000,000.00investing reconciliation → Property and equipment purchases, net: $327,000,000.00investing reconciliation → Renewable energy tax credit equity investments: $92,000,000.00investing reconciliation → Commercial mortgage loans: $34,000,000.00investing reconciliation → Other, net: $1,000,000.00Net cash used in financing activities → financing reconciliation: $3,681,000,000.00Issuance of common stock → financing reconciliation: $69,000,000.00Deposits and interest credited to contractholder deposit funds → financing reconciliation: $36,000,000.00financing reconciliation → Repurchase of common stock: $1,508,000,000.00financing reconciliation → Net change in short-term debt: $891,000,000.00financing reconciliation → Repayment of long-term debt: $700,000,000.00financing reconciliation → Common stock dividend paid: $412,000,000.00financing reconciliation → Other, net: $211,000,000.00financing reconciliation → Withdrawals and benefit payments from contractholder deposit funds: $64,000,000.00Exchange-rate effect → Cash sources and uses: $9,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $8,931,000,000.00Net cash from operating activities → Cash sources and uses: $1,920,000,000.00Net cash from investing activities → Cash sources and uses: $1,197,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $8,376,000,000.00Cash sources and uses → Net cash used in financing activities: $3,681,000,000.00Other, net: $260,000,000.00Other working capital, net+$260.00 MAccounts payable and Accrued expenses and other liabilities: -$1,174,000,000.00Accounts payable and Accrued expenses and otherliabilities−$1.17 BDeferred income tax benefit: -$216,000,000.00Deferred tax balances−$216.00 MDepreciation and amortization: $674,000,000.00Depreciation & amortization+$674.00 MInventories: $1,517,000,000.00Inventories+$1.52 BNet (loss) income: $1,409,000,000.00Net (loss) income+$1.41 BInsurance liabilities: $1,778,000,000.00Insurance liabilities+$1.78 BAccounts receivable, net: -$2,205,000,000.00Accounts & other receivables−$2.21 BInvestment losses, net: $2,000,000.00Investment losses, net+$2.00 MPharmacy and other service costs payable: $135,000,000.00Pharmacy and other service costs payable+$135.00 MReinsurance recoverable and Other assets: -$219,000,000.00Reinsurance recoverables−$219.00 M(Gain) loss on sale of businesses: -$41,000,000.00Business sale gain & loss−$41.00 MNet cash from operating activities: $1,920,000,000.00Operating cash+$1.92 BOperating adjustments reconciliation: $4,366,000,000.00Net change in short-term debt: -$891,000,000.00Net change in short-term debt−$891.00 MNet proceeds on issuance of long-term debt: $0.00Repayment of long-term debt: -$700,000,000.00Long-term debt repaid−$700.00 MOther, net: -$211,000,000.00Other financing, net−$211.00 MWithdrawals and benefit payments from contractholder deposit funds: -$64,000,000.00Policyholder withdrawals−$64.00 MRepurchase of common stock: -$1,508,000,000.00Common stock repurchases−$1.51 BCommon stock dividend paid: -$412,000,000.00Common dividends paid−$412.00 MIssuance of common stock: $69,000,000.00Common stock issued+$69.00 MDeposits and interest credited to contractholder deposit funds: $36,000,000.00Policyholder deposits+$36.00 MNet cash used in financing activities: -$3,681,000,000.00. Cash required to fund net payments.Financing cash−$3.68 Bfinancing reconciliation: $3,786,000,000.00Debt securities and equity securities: $94,000,000.00Debt securities and equity securities+$94.00 MOther sales, maturities and repayments (primarily short-term and other long-term investments): $331,000,000.00Other investment proceeds+$331.00 MOther (primarily short-term and other long-term investments): -$475,000,000.00Other investment purchases−$475.00 MOther, net: -$1,000,000.00Other investing, net−$1.00 MCommercial mortgage loans: -$34,000,000.00Mortgage note purchases−$34.00 MDebt securities and equity securities: $222,000,000.00Debt securities and equity securities+$222.00 MDivestitures, net of cash sold: $2,346,000,000.00Business sales, net of cash+$2.35 BDebt securities and equity securities: -$952,000,000.00Debt securities and equity securities−$952.00 MProperty and equipment purchases, net: -$327,000,000.00Property and equipment purchases, net−$327.00 MCommercial mortgage loans: $85,000,000.00Loan collections+$85.00 MRenewable energy tax credit equity investments: -$92,000,000.00Equity-method investments made−$92.00 MNet cash from investing activities: $1,197,000,000.00Investing cash+$1.20 Binvesting reconciliation: $3,078,000,000.00Cash sources and uses: $12,057,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $8,931,000,000.00Beginning cash$8.93 BEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $8,376,000,000.00Ending cash$8.38 BExchange-rate effect: $9,000,000.00FX effect+$9.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flowNot availableCash flow / Net income1.36×Operating cash flow ÷ net incomeNet cash change−$555.00 MEnding cash − beginning cash
Chart details

The Cigna Group cash flow reconciliation, Jan 1, 2025 through Mar 31, 2025

Cash flows for Jan 1, 2025 through Mar 31, 2025. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Dec 31, 2024. Ending cash: Mar 31, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2024
8,931,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
1,920,000,000 US dollars. Net cash provided.
Other, net
260,000,000 US dollars
Accounts payable and Accrued expenses and other liabilities
negative 1,174,000,000 US dollars
Deferred income tax benefit
negative 216,000,000 US dollars
Depreciation and amortization
674,000,000 US dollars
Inventories
1,517,000,000 US dollars
Net (loss) income
1,409,000,000 US dollars
Insurance liabilities
1,778,000,000 US dollars
Accounts receivable, net
negative 2,205,000,000 US dollars
Investment losses, net
2,000,000 US dollars
Pharmacy and other service costs payable
135,000,000 US dollars
Reinsurance recoverable and Other assets
negative 219,000,000 US dollars
(Gain) loss on sale of businesses
negative 41,000,000 US dollars
Investing activities
1,197,000,000 US dollars. Net cash provided.
Debt securities and equity securities
94,000,000 US dollars
Other sales, maturities and repayments (primarily short-term and other long-term investments)
331,000,000 US dollars
Other (primarily short-term and other long-term investments)
negative 475,000,000 US dollars
Other, net
negative 1,000,000 US dollars
Commercial mortgage loans
negative 34,000,000 US dollars
Debt securities and equity securities
222,000,000 US dollars
Divestitures, net of cash sold
2,346,000,000 US dollars
Debt securities and equity securities
negative 952,000,000 US dollars
Property and equipment purchases, net
negative 327,000,000 US dollars
Commercial mortgage loans
85,000,000 US dollars
Renewable energy tax credit equity investments
negative 92,000,000 US dollars
Financing activities
negative 3,681,000,000 US dollars. Net cash used.
Net change in short-term debt
negative 891,000,000 US dollars
Net proceeds on issuance of long-term debt
0 US dollars
Repayment of long-term debt
negative 700,000,000 US dollars
Other, net
negative 211,000,000 US dollars
Withdrawals and benefit payments from contractholder deposit funds
negative 64,000,000 US dollars
Repurchase of common stock
negative 1,508,000,000 US dollars
Common stock dividend paid
negative 412,000,000 US dollars
Issuance of common stock
69,000,000 US dollars
Deposits and interest credited to contractholder deposit funds
36,000,000 US dollars
Operating adjustment reconciliation
4,366,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
3,786,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
3,078,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
9,000,000 US dollars
Ending cash on Mar 31, 2025
8,376,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
12,057,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 555,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.36×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $511.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
The Cigna Group (CI) FY2025 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!